Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril.
Gliddon AE, Doré CJ, Black CM, McHugh N, Moots R, Denton CP, Herrick A, Barnes T, Camilleri J, Chakravarty K, Emery P, Griffiths B, Hopkinson ND, Hickling P, Lanyon P, Laversuch C, Lawson T, Mallya R, Nisar M, Rhys-Dillon C, Sheeran T, Maddison PJ.
Gliddon AE, et al. Among authors: dore cj.
Arthritis Rheum. 2007 Nov;56(11):3837-46. doi: 10.1002/art.22965.
Arthritis Rheum. 2007.
PMID: 17968938
Free article.
Clinical Trial.